The Brighterside of News on MSN
New research challenges our understanding of Parkinson’s disease
A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...
A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...
Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences' allogeneic ...
A groundbreaking treatment for Parkinson’s disease and essential tremor is now available in Kentucky and the Norton ...
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, NE / ACCESS Newswire / December 23, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A ...
Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.
Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.
Parkinson’s disease (PD) is a growing global health challenge, affecting millions worldwide and imposing significant burdens ...
Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...
Results of a recent study strongly suggest simply getting more B vitamins in your diet could be a completely painless way of ...
BIDMC Parkinson’s specialists diagnose and treat atypical Parkinson’s disease, a progressive movement disorder. Learn more.
People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results